User:Jeremy S. Myers
From OpenWetWare
(Difference between revisions)
Current revision (11:20, 14 August 2008) (view source) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Contact Info== | ==Contact Info== | ||
| - | [[Image:OWWEmblem.png|thumb|right| | + | [[Image:OWWEmblem.png|thumb|right|(an artistic interpretation)]] |
*Jeremy S. Myers, Ph.D. | *Jeremy S. Myers, Ph.D. | ||
| Line 20: | Line 20: | ||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
| - | # Targeted Mass Spectrometry-based | + | # Targeted Mass Spectrometry-based Proteomics |
# Targeted Therapeutics | # Targeted Therapeutics | ||
| Line 32: | Line 32: | ||
==Selected Protocols== | ==Selected Protocols== | ||
*[[Myers:EGFR_IP]] | *[[Myers:EGFR_IP]] | ||
| + | *[[Myers:synchronization]] | ||
Current revision
Contents |
Contact Info
- Jeremy S. Myers, Ph.D.
- AstraZeneca Fellow
- Advanced Targeted Proteomics Team Leader
- Vanderbilt University School of Medicine
- Mass Spectrometry Research Center
- Nashville, TN, U.S.A.
- jeremy.myers@vanderbilt.edu
for more information visit: http://www.advancedtargetedproteomics.com
Education
- 2003-2007 Postdoctoral Fellow
- 2003 Ph.D., Louisiana State University
- 1999 B.S., Bucknell University
Research interests
- Targeted Mass Spectrometry-based Proteomics
- Targeted Therapeutics
Publications (since 2007)
- Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878
